• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

Drug Discovery 2024 (ELRIG)

October 2 - 3, London, UK

Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification and disease modelling. This year’s Scientific Content Partners are the Cell & Gene Therapy Catapult, the Royal Society of Chemistry, SBi2 and SLAS, all of whom are providing science tracks prepared by their community members. And in the middle of all this science there is the exhibition hall, which is a great opportunity to meet over two hundred drug discovery suppliers and to learn about all the latest products and services you can use in your research.

Check out our posters:

Posters

  • Poster #105 "An automated and multiplexed liver fibrosis screening assay on a microfluidic liver model that replicates the cellular composition and organization of the hepatic lobule"
    Wednesday, Oct 2 2024, 17:00 - 17:30 & Thursday, 3 Oct 2024. 13:00 - 13:30
  • Poster #208 "Influencing drug responses through in vitro tumor microenvironment characteristics"
    Wednesday, Oct 2 2024, 17:00 - 17:30 & Thursday, 3 Oct 2024. 13:00 - 13:30

 

Schedule a meeting with us

 

Link to the conference homepage

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all